Continuous, hyperfractionated, accelerated radiotherapy(CHART) for head and neck neoplasms

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 9 Apr 2024: Trial registered, NCT06353685
  2. 1 May 2024: Trial started, NCT06353685

The trials

NCT06353685: De-Escalation Postoperative Radiotherapy for Oral Squamous Cell Carcinoma With pCR/MPR.

State
Under way
Phase
Phase 2
People
103 planned
Started
1 May 2024
Primary completion
31 Dec 2026
Arms
Continuous hyperfractionated accelerated radiotherapy(CHART)
Results
None posted
  1. 9 Apr 2024: Trial registered
  2. 1 May 2024: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.